Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies directed to tumor necrosis factor and uses thereof

Antibodies directed to tumor necrosis factor and uses thereof

US Patent 8101178 · Granted Jan 24, 2012

Estimated economic value: $65,525,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bivalent bispecific antibody and preparation method thereof, coding gene, host c2025
Engineered γδ T-cells2025
Methods for selective expansion of gamma delta t-cell populations and compositio2025
Anti-CD47 monoclonal antibody and use thereof2025
Anti-CD38 binding domains2025
Cytotoxic and anti-mitotic compounds, and methods of using the same2025
Humanized anti-A β monoclonal antibody and application thereof2025
Methods for selective expansion of delta-3 gamma delta T-cell populations and co2025
Anti-CD38 antibodies2025
Anti-podocalyxin antibodies and methods of using the same2024
Interleukin-2 muteins for the expansion of T-regulatory cells2024
Anti-B7-H1 antibodies for treating tumors2023